Alzheimer’s Clinical Trials Consortium – Down Syndrome
To provide an optimal infrastructure, utilizing centralized resources and shared expertise, to accelerate the development of effective interventions for Alzheimer’s disease in Down syndrome.
Trial Ready-Cohort for Down Syndrome (TRC-DS).
The ACTC-DS recently launched the Trial Ready-Cohort for Down syndrome (TRC-DS). TRC-DS will enroll 250 participants with DS into a longitudinal study which includes brain scans, blood tests, memory tests in advance of upcoming randomized, placebo-controlled clinical trials for Alzheimer’s disease in Down syndrome. Participants in TRC-DS will be provided the opportunity to enroll into these clinical trials aimed at preventing Alzheimer’s disease in Down syndrome.